Placenta
Volume 31, Issue 10 , Pages 919-927 , October 2010

Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction

  • D. Marzioni

      Affiliations

    • Department of Molecular Pathology and Innovative Therapies, Marche Polytechnic University, Via Tronto, 10/a - I-60126 Ancona, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 071 2206270; fax: +39 071 2206087.
    • D.M. and T.T. contributed equally to this work as first authors.
    • ,
  • T. Todros

      Affiliations

    • Department of Obstetrics and Gynecology, University of Turin, 10126 Turin, Italy
    • D.M. and T.T. contributed equally to this work as first authors.
    • ,
  • S. Cardaropoli

      Affiliations

    • Department of Obstetrics and Gynecology, University of Turin, 10126 Turin, Italy
    • ,
  • A. Rolfo

      Affiliations

    • Department of Obstetrics and Gynecology, University of Turin, 10126 Turin, Italy
    • ,
  • T. Lorenzi

      Affiliations

    • Department of Molecular Pathology and Innovative Therapies, Marche Polytechnic University, Via Tronto, 10/a - I-60126 Ancona, Italy
    • ,
  • P. Ciarmela

      Affiliations

    • Department of Molecular Pathology and Innovative Therapies, Marche Polytechnic University, Via Tronto, 10/a - I-60126 Ancona, Italy
    • ,
  • R. Romagnoli

      Affiliations

    • Department of Physiology, Division of Reproductive Physiology and Endocrinology, University of Siena, 53100 Siena, Italy
    • ,
  • L. Paulesu

      Affiliations

    • Department of Physiology, Division of Reproductive Physiology and Endocrinology, University of Siena, 53100 Siena, Italy
    • ,
  • M. Castellucci

      Affiliations

    • Department of Molecular Pathology and Innovative Therapies, Marche Polytechnic University, Via Tronto, 10/a - I-60126 Ancona, Italy

,Accepted 4 August 2010.

References 

  1. Mütze S, Rudnik-Schöneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. L Perinat Med. 2008;36:38–58
  2. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta. 1980;1:61–76
  3. Fox H. Pathology of the placenta. Clin Obstet Gynaecol. 1986;13:501–519
  4. Rainey A, Mayhew TM. Volumes and numbers of intervillous pores and villous domains in placentas associated with intrauterine growth restriction and/or pre-eclampsia. Placenta. 2010;31:602–606
  5. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract. 2007;106:c72–c81
  6. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594
  7. Hu Y, Peng J, Feng D, Chu L, Li X, Jin Z, et al. Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung. 2006;184:33–42
  8. Angel P, Karin M. The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129–157
  9. Schreiber M, Wang Z-Q, Jochum W, Fetka I, Elliott C, Warger EF. Placental vascularization requires the AP-1 component Fra 1. Development. 2000;127:4937–4948
  10. Bamberger AM, Bamberger CM, Aupers S, Milde-Langosch K, Löning T, Makrigiannakis A. Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol Hum Reprod. 2004;10:223–228
  11. Gifford DS, Morton SC, Fiske M, Keesey J, Keeler E, Kahn KL. Lack of progress in labor as a reason for cesarean. Obstet Gynecol. 2000;95:589–595
  12. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol. 1996;7:182–188
  13. Nicolini U, Ferrazzi E, Molla R, Massa E, Cicognani G, Santarone M, et al. Accuracy of an average ultrasonic laboratory in measurements of fetal biparietal diameter, head circumference and abdominal circumference. J Perinat Med. 1986;14:101–107
  14. Parazzini F, Cortinovis I, Bortolus R, Fedele L. Standard di peso alla nascita in Italia. Ann Ost Gin Med Perin. 1991;CXII:203–246
  15. Todros T, Ronco G, Fianchino O, Rosso S, Gabrielli S, Valsecchi L, et al. Accuracy of the umbilical arteries Doppler flow velocity waveforms in detecting adverse perinatal outcomes in a high-risk population. Acta Obstet Gynecol Scand. 1996;75:113–119
  16. Lorenzi T, Marzioni D, Giannubilo S, Quaranta A, Crescimanno C, De Luca A, et al. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Placenta. 2009;30(1):35–40
  17. ACOG Committee on Obstetric Practice . ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77:67–75
  18. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol. 1993;122:685–701
  19. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 1994;13:3094–3103
  20. Bakin AV, Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science. 1999;283:387–390
  21. Mikula M, Gotzmann J, Fischer AN, Wolschek MF, Thallinger C, Schulte-Hermann R, et al. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene. 2003;22:6725–6738
  22. Jin SP, Kim JH, Kim MA, Yang HK, Lee HE, Lee HS, et al. Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol Oncol Res. 2007;13:284–289
  23. Faxén M, Nasiell J, Lunell NO, Blanck A. Differences in mRNA expression of endothelin-1, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with preeclampsia and/or intrauterine growth retardation. Gynecol Obstet Invest. 1997;44:93–96
  24. Ahenkorah J, Hottor B, Byrne S, Bosio P, Ockleford CD. Immunofluorescence confocal laser scanning microscopy and immuno-electron microscopic identification of keratins in human materno-foetal interaction zone. J Cell Mol Med. 2009;4:735–748
  25. Andreucci JJ, Grant D, Cox DM, Tomc LK, Prywes R, Goldhamer DJ, et al. Composition and function of AP-1 transcription complexes during muscle cell differentiation. J Biol Chem. 2002;277:16426–16432
  26. Rusovici R, LaVoie HA. Expression and distribution of AP-1 transcription factors in the porcine ovary. Biol Reprod. 2003;69:64–74
  27. Liu C, Hadjiargyrou M. Identification and characterization of the Mustang promoter: regulation by AP-1 during myogenic differentiation. Bone. 2006;39:815–824

PII: S0143-4004(10)00296-1

doi: 10.1016/j.placenta.2010.08.001

Placenta
Volume 31, Issue 10 , Pages 919-927 , October 2010

Article Tools

* Image Usage & Resolution